| Product NDC: | 50114-6035 |
| Proprietary Name: | Bryaconeel |
| Non Proprietary Name: | ACONITUM NAPELLUS and BRYONIA ALBA ROOT and PHOSPHORUS |
| Active Ingredient(s): | 4; 4; 5 [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; ACONITUM NAPELLUS and BRYONIA ALBA ROOT and PHOSPHORUS |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50114-6035 |
| Labeler Name: | Heel Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 19840131 |
| Package NDC: | 50114-6035-2 |
| Package Description: | 100 TABLET in 1 BOTTLE (50114-6035-2) |
| NDC Code | 50114-6035-2 |
| Proprietary Name | Bryaconeel |
| Package Description | 100 TABLET in 1 BOTTLE (50114-6035-2) |
| Product NDC | 50114-6035 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | ACONITUM NAPELLUS and BRYONIA ALBA ROOT and PHOSPHORUS |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19840131 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | Heel Inc |
| Substance Name | ACONITUM NAPELLUS; BRYONIA ALBA ROOT; PHOSPHORUS |
| Strength Number | 4; 4; 5 |
| Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1 |
| Pharmaceutical Classes |